APA

Zhang M., Zhang Z., Garmestani K., Schultz J., Axworthy D. B., Goldman C. K., Brechbiel M. W., Carrasquillo J. A. & Waldmann T. A. (20030401). Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Zhang Meili, Zhang Zhuo, Garmestani Kayhan, Schultz Jody, Axworthy Donald B, Goldman Carolyn K, Brechbiel Martin W, Carrasquillo Jorge A and Waldmann Thomas A. 20030401. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Zhang M., Zhang Z., Garmestani K., Schultz J., Axworthy D. B., Goldman C. K., Brechbiel M. W., Carrasquillo J. A. and Waldmann T. A. (20030401). Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Zhang Meili, Zhang Zhuo, Garmestani Kayhan, Schultz Jody, Axworthy Donald B, Goldman Carolyn K, Brechbiel Martin W, Carrasquillo Jorge A and Waldmann Thomas A. Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts. : Proceedings of the National Academy of Sciences of the United States of America. 20030401.